Fifteen years ago, an analysis of drug molecules moving through the stages of clinical development suggested that increased three-dimensional character was a marker of greater success. Now, we perform a similar analysis to evaluate the impact of that landmark publication and to see if the trends observed then still hold today.
- Ian Churcher
- Stuart Newbold
- Christopher W. Murray
